The EGF receptor system as a target for antitumor therapy.
about
Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrestSomatic mutations of the epidermal growth factor receptor and non-small-cell lung cancerHydrogen/deuterium exchange mass spectrometry applied to IL-23 interaction characteristics: potential impact for therapeuticsFabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Targeting the EGFR signaling pathway in cancer therapy.Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contextsCombination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.The influence of adnectin binding on the extracellular domain of epidermal growth factor receptor.Fluorescent affibody peptide penetration in glioma margin is superior to full antibodyGemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer.Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interactionPrognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata.Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer.Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell linesCustomised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC)Implications of EGFR PharmDx kit for cetuximab eligibility.Anti-epidermal growth factor receptor strategies for advanced breast cancer.New insights into the regulation of the actin cytoskeleton by tropomyosin.Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningiomaChemotherapy for the biliary tract cancers: moving toward improved survival time.Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management.Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR.CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signaling.2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species.Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.In vitro metabolism of gefitinib in human liver microsomes.
P2860
Q24632971-9703C676-4F07-477C-B86A-527A838930CBQ24648133-CD90744C-25EC-46CA-B0B4-86FE76760FCAQ27004640-D0D8221D-39D8-41DD-98D4-5C2C195A3F73Q33684453-131492E7-E36A-4CB1-84B9-E06983F5BB62Q34246558-D3E14614-B21B-415A-8830-888E7CF7A1BFQ34287068-0AAE0530-4EDF-4622-8C73-1C6AB19CD141Q34465240-74328B7B-529F-4B13-BF7B-DBB671A3AE98Q34474034-0F3FF9E4-7620-43BA-907B-04457A537CE0Q34673086-76B670DB-AE9A-4CF5-ACCC-7E789DCD63E3Q35673927-A4F84A55-C21A-4B08-A5B0-DF3621C06730Q35975727-EE4856F4-8ADD-4B36-94B3-303A866EB999Q36080022-CFE84C30-4DC6-43CF-9F7B-7D7444CAE1FEQ36116438-7F6DA46E-A344-4CB6-90CA-FB06E78B4761Q36246406-31AC8792-C6DF-4B36-B2B6-27A9226925B7Q36772562-B506295C-65E0-4A3C-B982-DE2FE93D7785Q36982771-A32B3542-C575-4D05-8B41-6C7688E94721Q36996220-BAEE8EDE-62B0-4DF9-829C-915554ED8D3AQ37118974-508991CF-F639-4117-8320-A5BE7FE63A06Q37293327-F9246B10-97BC-4F44-8ADD-0C4F48C1B34DQ37749050-D31C8025-3611-40B5-A520-E8AAAEF5FFB1Q37761398-69411CBC-17C6-4FBA-BA5A-0AAC5F7C5F70Q37983498-90144CEA-6DFA-402D-9E27-53932F6C1332Q38133409-48F53DB7-4B63-421F-8C7C-AF30C1D3B90CQ38696292-6B765B02-E88E-400C-B84D-B30DD6963326Q38993980-A1CB04F6-F2E5-4E6F-82AF-73CF6D1B859DQ40609744-34A2D093-C347-481D-83CB-C148A4629DA4Q42497044-17F1E9ED-E444-45EF-BE1E-6618119DD18CQ46413695-955D6E0D-55ED-4078-B12D-296394706810
P2860
The EGF receptor system as a target for antitumor therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The EGF receptor system as a target for antitumor therapy.
@en
The EGF receptor system as a target for antitumor therapy.
@nl
type
label
The EGF receptor system as a target for antitumor therapy.
@en
The EGF receptor system as a target for antitumor therapy.
@nl
prefLabel
The EGF receptor system as a target for antitumor therapy.
@en
The EGF receptor system as a target for antitumor therapy.
@nl
P2093
P2860
P1433
P1476
The EGF receptor system as a target for antitumor therapy.
@en
P2093
P2860
P304
P356
10.3109/07357909109018953
P577
1991-01-01T00:00:00Z